Advertisement

Index by Author

June 1999; 22 (6)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ackerson, L M

    • Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care June 1999 22:938-943; doi:10.2337/diacare.22.6.938

  2. Ahroni, J H

    • Clinical correlates of plantar pressure among diabetic veterans. Diabetes Care June 1999 22:965-972; doi:10.2337/diacare.22.6.965

B

  1. Bantle, J P

    • Pharmacologic induction of weight loss to treat type 2 diabetes. Diabetes Care June 1999 22:896-903; doi:10.2337/diacare.22.6.896

  2. Baron, A D

    • Impaired glucose tolerance. Why is it not a disease? Diabetes Care June 1999 22:883-885; doi:10.2337/diacare.22.6.883

  3. Belicar, P

    • Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth. Diabetes Care June 1999 22:1001-1002; doi:10.2337/diacare.22.6.1001

  4. Bell, D S

    • Gastroparesis cured by gastrectomy. Diabetes Care June 1999 22:1000-1001; doi:10.2337/diacare.22.6.1000

  5. Benhaddad, A A

    • Revised concept for the estimation of insulin sensitivity from a single sample. Diabetes Care June 1999 22:1003-1004; doi:10.2337/diacare.22.6.1003

  6. Bennett, P H

    • Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care June 1999 22:944-950; doi:10.2337/diacare.22.6.944

  7. Bergholm, R

    • Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973

  8. Blonde, L

    • Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin. Diabetes Care June 1999 22:1004-1006; doi:10.2337/diacare.22.6.1004a

  9. Bloomgarden, Z T

    • The European Association for the Study of Diabetes Annual Meeting, 1998. The U.K. Prospective Diabetes Study and other topics in type 2 diabetes. Diabetes Care June 1999 22:989-995; doi:10.2337/diacare.22.6.989

  10. Bodansky, H J

    • Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K. Diabetes Care June 1999 22:928-932; doi:10.2337/diacare.22.6.928

  11. Boivin, S

    • Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth. Diabetes Care June 1999 22:1001-1002; doi:10.2337/diacare.22.6.1001

  12. Bouma, M

    • How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care June 1999 22:904-907; doi:10.2337/diacare.22.6.904

  13. Boyko, E J

    • Clinical correlates of plantar pressure among diabetic veterans. Diabetes Care June 1999 22:965-972; doi:10.2337/diacare.22.6.965

  14. Brighenti, F

    • Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care June 1999 22:913-919; doi:10.2337/diacare.22.6.913

  15. Bruce-Thompson, C

    • Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care June 1999 22:913-919; doi:10.2337/diacare.22.6.913

  16. Brun, J F

    • Revised concept for the estimation of insulin sensitivity from a single sample. Diabetes Care June 1999 22:1003-1004; doi:10.2337/diacare.22.6.1003

  17. Butler-Jones, D

    • Incidence of lactic acidosis in metformin users. Diabetes Care June 1999 22:925-927; doi:10.2337/diacare.22.6.925

C

  1. Casey, E

    • Central pontine myelinolysis. An unusual complication of diabetes. Diabetes Care June 1999 22:998-1000; doi:10.2337/diacare.22.6.998

  2. Clifton, P M

    • Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care June 1999 22:889-895; doi:10.2337/diacare.22.6.889

  3. Cohen, R D

    • Metformin and lactic acidosis. Diabetes Care June 1999 22:1010-1011; doi:10.2337/diacare.22.6.1010

  4. Cull, C A

    • A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44) Diabetes Care June 1999 22:960-964; doi:10.2337/diacare.22.6.960

D

  1. Dabelea, D

    • Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care June 1999 22:944-950; doi:10.2337/diacare.22.6.944

  2. Dekker, J H

    • How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care June 1999 22:904-907; doi:10.2337/diacare.22.6.904

  3. de Sonnaville, J J

    • How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care June 1999 22:904-907; doi:10.2337/diacare.22.6.904

  4. de Swiet, M

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

  5. de Vries, H

    • How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care June 1999 22:904-907; doi:10.2337/diacare.22.6.904

  6. Dornhorst, A

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

E

  1. Eguchi, H

    • Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care June 1999 22:920-924; doi:10.2337/diacare.22.6.920

  2. Epstein, M

    • Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications. Diabetes Care June 1999 22:982-988; doi:10.2337/diacare.22.6.982

  3. Evans, A

    • Central pontine myelinolysis. An unusual complication of diabetes. Diabetes Care June 1999 22:998-1000; doi:10.2337/diacare.22.6.998

F

  1. Ferrara, A

    • Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care June 1999 22:938-943; doi:10.2337/diacare.22.6.938

  2. Forsberg, R C

    • Clinical correlates of plantar pressure among diabetic veterans. Diabetes Care June 1999 22:965-972; doi:10.2337/diacare.22.6.965

  3. Fukui, M

    • GAD antibodies in classification of Asian type 2 diabetes. Diabetes Care June 1999 22:1011-1012; doi:10.2337/diacare.22.6.1011

G

  1. Gatta, B

    • Diabetic ketoacidosis with olanzapine treatment. Diabetes Care June 1999 22:1002-1003; doi:10.2337/diacare.22.6.1002

  2. Gin, H

    • Diabetic ketoacidosis with olanzapine treatment. Diabetes Care June 1999 22:1002-1003; doi:10.2337/diacare.22.6.1002

  3. Grenfell, A

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

  4. Gross, P

    • Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth. Diabetes Care June 1999 22:1001-1002; doi:10.2337/diacare.22.6.1001

  5. Gumbiner, B

    • Treating obesity in type 2 diabetes. Calories, composition, and control. Diabetes Care June 1999 22:886-888; doi:10.2337/diacare.22.6.886

  6. Gunczler, P

    • Poor metabolic control decreases the growth velocity of diabetic children. Diabetes Care June 1999 22:1012; doi:10.2337/diacare.22.6.1012

  7. Gurney, K A

    • Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K. Diabetes Care June 1999 22:928-932; doi:10.2337/diacare.22.6.928

  8. Guthrie, R D, Jr

    • Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin. Diabetes Care June 1999 22:1004-1006; doi:10.2337/diacare.22.6.1004a

H

  1. Hänninen, J A

    • Depression in subjects with type 2 diabetes. Predictive factors and relation to quality of life. Diabetes Care June 1999 22:997-998; doi:10.2337/diacare.22.6.997

  2. Hanson, R L

    • Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care June 1999 22:944-950; doi:10.2337/diacare.22.6.944

  3. Heilbronn, L K

    • Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care June 1999 22:889-895; doi:10.2337/diacare.22.6.889

  4. Heine, R J

    • How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care June 1999 22:904-907; doi:10.2337/diacare.22.6.904

  5. Holman, R R

    • A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44) Diabetes Care June 1999 22:960-964; doi:10.2337/diacare.22.6.960

  6. Hopkins, D

    • Central pontine myelinolysis. An unusual complication of diabetes. Diabetes Care June 1999 22:998-1000; doi:10.2337/diacare.22.6.998

  7. Horikoshi, H

    • Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care June 1999 22:908-912; doi:10.2337/diacare.22.6.908

  8. Hunkert, F

    • Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes. Diabetes Care June 1999 22:1008-1010; doi:10.2337/diacare.22.6.1008

I

  1. Igarashi, K

    • Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care June 1999 22:920-924; doi:10.2337/diacare.22.6.920

  2. Ikeda, Y

    • Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care June 1999 22:908-912; doi:10.2337/diacare.22.6.908

  3. Imperatore, G

    • Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care June 1999 22:944-950; doi:10.2337/diacare.22.6.944

J

  1. Jeandidier, N

    • Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth. Diabetes Care June 1999 22:1001-1002; doi:10.2337/diacare.22.6.1001

  2. Jenkins, D J

    • Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care June 1999 22:913-919; doi:10.2337/diacare.22.6.913

  3. Johnston, D G

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

  4. Josse, R

    • Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care June 1999 22:913-919; doi:10.2337/diacare.22.6.913

K

  1. Karter, A J

    • Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care June 1999 22:938-943; doi:10.2337/diacare.22.6.938

  2. Kato, T

    • Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care June 1999 22:920-924; doi:10.2337/diacare.22.6.920

  3. Keinänen-Kiukaanniemi, S M

    • Depression in subjects with type 2 diabetes. Predictive factors and relation to quality of life. Diabetes Care June 1999 22:997-998; doi:10.2337/diacare.22.6.997

  4. Kiess, W

    • Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes. Diabetes Care June 1999 22:1008-1010; doi:10.2337/diacare.22.6.1008

  5. Klein, B E

    • The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care June 1999 22:951-959; doi:10.2337/diacare.22.6.951

  6. Klein, R

    • The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care June 1999 22:951-959; doi:10.2337/diacare.22.6.951

  7. Knowler, W C

    • Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care June 1999 22:944-950; doi:10.2337/diacare.22.6.944

  8. Kobayashi, K

    • Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men. Diabetes Care June 1999 22:1004; doi:10.2337/diacare.22.6.1004b

  9. Kondo, M

    • GAD antibodies in classification of Asian type 2 diabetes. Diabetes Care June 1999 22:1011-1012; doi:10.2337/diacare.22.6.1011

  10. Kostense, P J

    • How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care June 1999 22:904-907; doi:10.2337/diacare.22.6.904

  11. Kousta, E

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

  12. Krentz, A

    • Central pontine myelinolysis. An unusual complication of diabetes. Diabetes Care June 1999 22:998-1000; doi:10.2337/diacare.22.6.998

  13. Kriegsman, D M

    • How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care June 1999 22:904-907; doi:10.2337/diacare.22.6.904

  14. Kwong, C A

    • Pharmacologic induction of weight loss to treat type 2 diabetes. Diabetes Care June 1999 22:896-903; doi:10.2337/diacare.22.6.896

L

  1. Lahdenperä, S

    • Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973

  2. Lanes, R

    • Poor metabolic control decreases the growth velocity of diabetic children. Diabetes Care June 1999 22:1012; doi:10.2337/diacare.22.6.1012

  3. Lassmann-Vague, V

    • Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth. Diabetes Care June 1999 22:1001-1002; doi:10.2337/diacare.22.6.1001

  4. Law, G R

    • Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K. Diabetes Care June 1999 22:928-932; doi:10.2337/diacare.22.6.928

  5. Lawrence, N J

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

  6. Leiter, L A

    • Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care June 1999 22:913-919; doi:10.2337/diacare.22.6.913

  7. Lietz, T

    • Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes. Diabetes Care June 1999 22:1008-1010; doi:10.2337/diacare.22.6.1008

  8. Liu, M L

    • Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973

M

  1. Mackay, I R

    • GAD antibodies in elderly men in different categories of glucose tolerance. Diabetes Care June 1999 22:996-997; doi:10.2337/diacare.22.6.996

  2. Mäkimattila, S

    • Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973

  3. Manaka, H

    • Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care June 1999 22:920-924; doi:10.2337/diacare.22.6.920

  4. Mäntysaari, M

    • Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973

  5. Mather, H M

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

  6. McCarthy, M I

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

  7. McKinney, P A

    • Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K. Diabetes Care June 1999 22:928-932; doi:10.2337/diacare.22.6.928

  8. Mercier, J

    • Revised concept for the estimation of insulin sensitivity from a single sample. Diabetes Care June 1999 22:1003-1004; doi:10.2337/diacare.22.6.1003

  9. Millauer, B A

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

  10. Mitchell, B D

    • Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care June 1999 22:938-943; doi:10.2337/diacare.22.6.938

  11. Mora, C

    • Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy. Diabetes Care June 1999 22:1006-1008; doi:10.2337/diacare.22.6.1006

  12. Mori, Y

    • Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care June 1999 22:908-912; doi:10.2337/diacare.22.6.908

  13. Moss, S E

    • The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care June 1999 22:951-959; doi:10.2337/diacare.22.6.951

  14. Murakawa, Y

    • Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care June 1999 22:908-912; doi:10.2337/diacare.22.6.908

N

  1. Nagai, Y

    • Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men. Diabetes Care June 1999 22:1004; doi:10.2337/diacare.22.6.1004b

  2. Nakamura, N

    • GAD antibodies in classification of Asian type 2 diabetes. Diabetes Care June 1999 22:1011-1012; doi:10.2337/diacare.22.6.1011

  3. Navarro, J F

    • Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy. Diabetes Care June 1999 22:1006-1008; doi:10.2337/diacare.22.6.1006

  4. Newman, B

    • Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care June 1999 22:938-943; doi:10.2337/diacare.22.6.938

  5. Nissinen, A

    • GAD antibodies in elderly men in different categories of glucose tolerance. Diabetes Care June 1999 22:996-997; doi:10.2337/diacare.22.6.996

  6. Noakes, M

    • Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care June 1999 22:889-895; doi:10.2337/diacare.22.6.889

  7. Nohara, E

    • Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men. Diabetes Care June 1999 22:1004; doi:10.2337/diacare.22.6.1004b

O

  1. Okada, K

    • Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care June 1999 22:908-912; doi:10.2337/diacare.22.6.908

  2. Ovalle, F

    • Gastroparesis cured by gastrectomy. Diabetes Care June 1999 22:1000-1001; doi:10.2337/diacare.22.6.1000

  3. Owen, R

    • Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care June 1999 22:913-919; doi:10.2337/diacare.22.6.913

P

  1. Parslow, R

    • Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K. Diabetes Care June 1999 22:928-932; doi:10.2337/diacare.22.6.928

  2. Penny, A

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

  3. Perez-Martin, A

    • Revised concept for the estimation of insulin sensitivity from a single sample. Diabetes Care June 1999 22:1003-1004; doi:10.2337/diacare.22.6.1003

  4. Perry, R C

    • Impaired glucose tolerance. Why is it not a disease? Diabetes Care June 1999 22:883-885; doi:10.2337/diacare.22.6.883

  5. Pettitt, D J

    • Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care June 1999 22:944-950; doi:10.2337/diacare.22.6.944

  6. Pinget, M

    • Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth. Diabetes Care June 1999 22:1001-1002; doi:10.2337/diacare.22.6.1001

  7. Preston, R A

    • Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications. Diabetes Care June 1999 22:982-988; doi:10.2337/diacare.22.6.982

R

  1. Raatz, S K

    • Pharmacologic induction of weight loss to treat type 2 diabetes. Diabetes Care June 1999 22:896-903; doi:10.2337/diacare.22.6.896

  2. Raynaud, E

    • Revised concept for the estimation of insulin sensitivity from a single sample. Diabetes Care June 1999 22:1003-1004; doi:10.2337/diacare.22.6.1003

  3. Redmon, J B

    • Pharmacologic induction of weight loss to treat type 2 diabetes. Diabetes Care June 1999 22:896-903; doi:10.2337/diacare.22.6.896

  4. Renard, E

    • Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth. Diabetes Care June 1999 22:1001-1002; doi:10.2337/diacare.22.6.1001

  5. Rigalleau, V

    • Diabetic ketoacidosis with olanzapine treatment. Diabetes Care June 1999 22:1002-1003; doi:10.2337/diacare.22.6.1002

  6. Robinson, S

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

  7. Rowell, S E

    • Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care June 1999 22:938-943; doi:10.2337/diacare.22.6.938

  8. Rowley, M J

    • GAD antibodies in elderly men in different categories of glucose tolerance. Diabetes Care June 1999 22:996-997; doi:10.2337/diacare.22.6.996

S

  1. Sandberg, M I

    • Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin. Diabetes Care June 1999 22:1004-1006; doi:10.2337/diacare.22.6.1004a

  2. Schlenzka, A

    • Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973

  3. Sekikawa, A

    • Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care June 1999 22:920-924; doi:10.2337/diacare.22.6.920

  4. Selby, J V

    • Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care June 1999 22:938-943; doi:10.2337/diacare.22.6.938

  5. Sievenpiper, J L

    • Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care June 1999 22:913-919; doi:10.2337/diacare.22.6.913

  6. Spadafora, P

    • Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care June 1999 22:913-919; doi:10.2337/diacare.22.6.913

  7. Stach, B

    • Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes. Diabetes Care June 1999 22:1008-1010; doi:10.2337/diacare.22.6.1008

  8. Stang, M

    • Incidence of lactic acidosis in metformin users. Diabetes Care June 1999 22:925-927; doi:10.2337/diacare.22.6.925

  9. Steer, P J

    • Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933

  10. Summanen, P

    • Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973

  11. Swanson, J E

    • Pharmacologic induction of weight loss to treat type 2 diabetes. Diabetes Care June 1999 22:896-903; doi:10.2337/diacare.22.6.896

  12. Syvänne, M

    • Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973

T

  1. Tajima, N

    • Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care June 1999 22:908-912; doi:10.2337/diacare.22.6.908

  2. Takala, J K

    • Depression in subjects with type 2 diabetes. Predictive factors and relation to quality of life. Diabetes Care June 1999 22:997-998; doi:10.2337/diacare.22.6.997

  3. Takamura, T

    • Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men. Diabetes Care June 1999 22:1004; doi:10.2337/diacare.22.6.1004b

  4. Taskinen, M R

    • Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973

  5. Thomas, W

    • Pharmacologic induction of weight loss to treat type 2 diabetes. Diabetes Care June 1999 22:896-903; doi:10.2337/diacare.22.6.896

  6. Tominaga, M

    • Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care June 1999 22:920-924; doi:10.2337/diacare.22.6.920

  7. Tuomilehto, J

    • GAD antibodies in elderly men in different categories of glucose tolerance. Diabetes Care June 1999 22:996-997; doi:10.2337/diacare.22.6.996

  8. Tuomilehto-Wolf, E

    • GAD antibodies in elderly men in different categories of glucose tolerance. Diabetes Care June 1999 22:996-997; doi:10.2337/diacare.22.6.996

  9. Turner, R C

    • A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44) Diabetes Care June 1999 22:960-964; doi:10.2337/diacare.22.6.960

V

  1. Vakkilainen, J

    • Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973

  2. van der Does, F E

    • How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care June 1999 22:904-907; doi:10.2337/diacare.22.6.904

  3. van Eijk, J T

    • How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care June 1999 22:904-907; doi:10.2337/diacare.22.6.904

  4. Vidgen, E

    • Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care June 1999 22:913-919; doi:10.2337/diacare.22.6.913

  5. Vuksan, V

    • Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care June 1999 22:913-919; doi:10.2337/diacare.22.6.913

W

  1. Watkins, P

    • Central pontine myelinolysis. An unusual complication of diabetes. Diabetes Care June 1999 22:998-1000; doi:10.2337/diacare.22.6.998

  2. Williams, R

    • Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K. Diabetes Care June 1999 22:928-932; doi:10.2337/diacare.22.6.928

  3. Woods, H F

    • Metformin and lactic acidosis. Diabetes Care June 1999 22:1010-1011; doi:10.2337/diacare.22.6.1010

  4. Wysowski, D K

    • Incidence of lactic acidosis in metformin users. Diabetes Care June 1999 22:925-927; doi:10.2337/diacare.22.6.925

Y

  1. Yamashita, H

    • Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men. Diabetes Care June 1999 22:1004; doi:10.2337/diacare.22.6.1004b

  2. Yki-Järvinen, H

    • Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973

  3. Ylihärsilä, H

    • GAD antibodies in elderly men in different categories of glucose tolerance. Diabetes Care June 1999 22:996-997; doi:10.2337/diacare.22.6.996

  4. Yokoyama, J

    • Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care June 1999 22:908-912; doi:10.2337/diacare.22.6.908

Z

  1. Zimmet, P

    • GAD antibodies in elderly men in different categories of glucose tolerance. Diabetes Care June 1999 22:996-997; doi:10.2337/diacare.22.6.996

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement